ALEXANDRIA LEIGH Brackett

Ms. ALEXANDRIA LEIGH Brackett

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2025 in JMIR AI
Verified
Journal Article
Open access
NKNaga Sasidhar Kanaparthy
Naga Sasidhar Kanaparthy
Yenny Villuendas-ReyYenny Villuendas-Rey
Yenny Villuendas-Rey
TBTolulope Bakare
Tolulope Bakare
ZDZihan Diao
Zihan Diao
MIMark Iscoe
Mark Iscoe
RTR Andrew Taylor
R Andrew Taylor
Background: As physicians spend up to twice as much time on electronic health record tasks as on direct patient care, digital scribes have emerged as a promising solution to restore patient-clinician communication and reduce documentation burden—making it essential to study their real-world impact on clinical workflows, efficiency, and satisfaction. Objective: This study aimed to synthesize evidence on clinician efficiency, user satisfaction, quality, and practical barriers associated with the use of digital scribes using ambient listening and generative artificial intelligence (AI) in real-world clinical settings. Methods: A rapid review was conducted to evaluate the real-world evidence of digital scribes using ambient listening and generative AI in clinical practice from 2014 to 2024. Data were collected from Ovid MEDLINE, Embase, Web of Science–Core Collection, Cochrane CENTRAL and Reviews, and PubMed Central. Predefined eligibility criteria focused on studies addressing clinical implementation, excluding those centered solely on technical development or model validation. The findings of each study were synthesized and analyzed through the QUEST human evaluation framework for quality and safety and the Systems Engineering Initiative for Patient Safety (SEIPS) 3.0 model to assess integration into clinicians’ workflows and experience. Results: Of the 1450 studies identified, 6 met the inclusion criteria. These studies included an observational study, a case report, a peer-matched cohort study, and survey-based assessments conducted across academic health systems, community settings, and outpatient practices. The major themes noted were as follows: (1) they decreased self-reported documentation times, with associated increased length of notes; (2) physician burnout measured using standardized scales was unaffected, but physician engagement improved; (3) physician productivity, assessed via billing metrics, was unchanged; and (4) the studies fell short when compared to standardized frameworks. Conclusions: Digital scribes show promise in reducing documentation burden and enhancing clinician satisfaction, thereby supporting workflow efficiency. However, the currently available evidence is sparse. Future real-world, multifaceted studies are needed before AI scribes can be recommended unequivocally.

27 September 2019 in Pain Medicine
Verified
Journal Article
Closed access
KCKelsey L Corcoran
Kelsey L Corcoran
LBLori A Bastian
Lori A Bastian
CGCraig G Gunderson
Craig G Gunderson
CSCatherine Steffens
Catherine Steffens
ABALEXANDRIA LEIGH Brackett
ALEXANDRIA LEIGH Brackett
ALAnthony J Lisi
Anthony J Lisi
Objective: To investigate the current evidence to determine if there is an association between chiropractic use and opioid receipt. Design: Systematic review and meta-analysis. Methods: The protocol for this review was registered on PROSPERO (CRD42018095128). The MEDLINE, PubMed, EMBASE, AMED, CINAHL, and Web of Science databases were searched for relevant articles from database inception through April 18, 2018. Controlled studies, cohort studies, and case–control studies including adults with noncancer pain were eligible for inclusion. Studies reporting opioid receipt for both subjects who used chiropractic care and nonusers were included. Data extraction and risk of bias assessment were completed independently by pairs of reviewers. Meta-analysis was performed and presented as an odds ratio with 95% confidence interval. Results: In all, 874 articles were identified. After detailed selection, 26 articles were reviewed in full, and six met the inclusion criteria. Five studies focused on back pain and one on neck pain. The prevalence of chiropractic care among patients with spinal pain varied between 11.3% and 51.3%. The proportion of patients receiving an opioid prescription was lower for chiropractic users (range = 12.3–57.6%) than nonusers (range = 31.2–65.9%). In a random-effects analysis, chiropractic users had a 64% lower odds of receiving an opioid prescription than nonusers (odds ratio = 0.36, 95% confidence interval = 0.30–0.43, P < 0.001, I2 = 92.8%). Conclusions: This review demonstrated an inverse association between chiropractic use and opioid receipt among patients with spinal pain. Further research is warranted to assess this association and the implications it may have for case management strategies to decrease opioid use.

8 March 2022 in Cancers
Verified
Journal Article
Open access
PDF file
Leon JekelLeon Jekel
Leon Jekel
WBWaverly R. Brim
Waverly R. Brim
MRMarc von Reppert
Marc von Reppert
LSLawrence Staib
Lawrence Staib
GPGabriel Cassinelli Petersen
Gabriel Cassinelli Petersen
MAMariam S. Aboian
Mariam S. Aboian
Glioma and brain metastasis can be difficult to distinguish on conventional magnetic resonance imaging (MRI) due to the similarity of imaging features in specific clinical circumstances. Multiple studies have investigated the use of machine learning (ML) models for non-invasive differentiation of glioma from brain metastasis. Many of the studies report promising classification results, however, to date, none have been implemented into clinical practice. After a screening of 12,470 studies, we included 29 eligible studies in our systematic review. From each study, we aggregated data on model design, development, and best classifiers, as well as quality of reporting according to the TRIPOD statement. In a subset of eligible studies, we conducted a meta-analysis of the reported AUC. It was found that data predominantly originated from single-center institutions (n = 25/29) and only two studies performed external validation. The median TRIPOD adherence was 0.48, indicating insufficient quality of reporting among surveyed studies. Our findings illustrate that despite promising classification results, reliable model assessment is limited by poor reporting of study design and lack of algorithm validation and generalizability. Therefore, adherence to quality guidelines and validation on outside datasets is critical for the clinical translation of ML for the differentiation of glioma and brain metastasis.

31 March 2022 in American Journal of Neuroradiology
Verified
Journal Article
Closed access
PDF file
GPG.I. Cassinelli Petersen
G.I. Cassinelli Petersen
JSJ. Shatalov
J. Shatalov
TVT. Verma
T. Verma
WBW.R. Brim
W.R. Brim
HSH. Subramanian
H. Subramanian
MAMariam S. Aboian
Mariam S. Aboian
Aims Long QT syndrome type 2 (LQT2) is caused by mutations in the gene KCNH2, encoding the hERG ion channel. Clinically, mild and severe phenotypes are associated with this cardiac channelopathy, complicating efforts to predict patient risk. The location of the mutation within KCNH2 contributes to this variable disease manifestation. Here we determined whether such phenotypic differences could be detected in cardiomyocytes derived from isogenic human induced pluripotent stem cells (hiPSCs) genetically edited to harbour a range of KCNH2 mutations. Methods and Results The hiPSC lines heterozygous for missense mutations either within the pore or tail region of the ion channel were generated using CRISPR-Cas9 editing and subsequently differentiated to cardiomyocytes (hiPSC-CMs) for functional assessment. Electrophysiological analysis confirmed the mutations prolonged the action potentials and field potentials of the hiPSC-CMs, with differences detected between the pore and tail region mutations when measured as paced 2D monolayers. This was also reflected in the cytosolic Ca2+ transients and contraction kinetics of the different lines. Pharmacological blocking of the hERG channel in the hiPSC-CMs also revealed that mutations in the pore-loop region conferred a greater susceptibility to arrhythmic events. Conclusion These findings establish that subtle phenotypic differences related to the location of the KCNH2 mutation in LQT2 patients are reflected in hiPSC-CMs under genetically controlled conditions. Moreover, the results validate hiPSC-CMs as a strong candidate for evaluating the underlying severity of individual KCNH2 mutations in humans which could ultimately facilitate patient risk stratification. Translational perspective Clinical management of patients diagnosed with cardiac channelopathy diseases such as LQT2 is complicated by the variable disease phenotypes observed among mutation carriers, creating challenges for diagnosis, risk stratification and treatment. The genotype of the patient contributes to this clinical heterogeneity, with the influence of the mutation’s location within KCNH2 on a patient’s risk of a cardiac event being an example. Here we demonstrate that under stringently controlled genetic and experimental conditions, hiPSC-CMs are able to reflect these subtle genotype-phenotype differences, thereby providing new opportunities to stratify and potentially lessen sudden cardiac death risk amongst KCNH2 mutation carriers.

7 June 2019 in Neuroradiology
Verified
Journal Article
Closed access
PDF file
Sam PayabvashSam Payabvash
Sam Payabvash
ABALEXANDRIA LEIGH Brackett
ALEXANDRIA LEIGH Brackett
RFReza Forghani
Reza Forghani
AMAjay Malhotra
Ajay Malhotra

13 July 2023 in Journal of Vascular Surgery: Venous and Lymphatic Disorders
Verified
Journal Article
Closed access
KSKarim Saab
Karim Saab
ABAnand S. Brahmandam
Anand S. Brahmandam
ABALEXANDRIA LEIGH Brackett
ALEXANDRIA LEIGH Brackett
MDMayur M. Desai
Mayur M. Desai
ADAlan Dardik
Alan Dardik
CCCassius Iyad Ochoa Chaar
Cassius Iyad Ochoa Chaar